FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1964037690> ?p ?o ?g. }

• W1964037690 endingPage "104" @default.
• W1964037690 startingPage "94" @default.
• W1964037690 abstract "Compounds containing a 1-cyanopyrrolidinyl ring were identified as potent and reversible inhibitors of cathepsins K and L. The original lead compound 1 inhibits cathepsins K and L with IC(50) values of 0. 37 and 0.45 M, respectively. Modification of compound 1 by replacement of the quinoline moiety led to the synthesis of N-(1-cyano-3-pyrrolidinyl)benzenesulfonamide (2). Compound 2 was found to be a potent inhibitor of cathepsins K and L with a K(i) value of 50 nM for cathepsin K. Replacement of the 1-cyanopyrrolidine of compound 2 by a 1-cyanoazetidine increased the potency of the inhibitor by 10-fold. This increase in potency is probably due to an enhanced chemical reactivity of the compound toward the thiolate of the active site of the enzyme. This is demonstrated when the assay is performed in the presence of glutathione at pH 7.0 which favors the formation of a GSH thiolate anion. Under these assay conditions, there is a loss of potency in the 1-cyanoazetidine series due to the formation of an inactive complex between the GSH thiolate and the 1-cyanoazetidine inhibitors. 1-Cyanopyrrolidinyl inhibitors exhibited time-dependent inhibition which allowed us to determine the association and dissociation rate constants with human cathepsin K. The kinetic data obtained showed that the increase of potency observed between different 1-cyanopyrrolidinyl inhibitors is due to an increase of k(on) values and that the association of the compound with the enzyme fits an apparent one-step mechanism. (13)C NMR experiments performed with the enzyme papain showed that compound 2 forms a covalent isothiourea ester adduct with the enzyme. As predicted by the kinetic analysis, the addition of the irreversible inhibitor E64 to the enzyme-cyanopyrrolidinyl complex totally abolished the signal of the isothiourea bond as observed by (13)C NMR, thereby demonstrating that the formation of the covalent bond with the active site cysteine residue is reversible. Finally, compound 2 inhibits bone resorption in an in vitro assay involving rabbit osteoclasts and bovine bone with an IC(50) value of 0.7 M. 1-Cyanopyrrolidine represents a new class of nonpeptidic compounds that inhibit cathepsin K and L activity and proteolysis of bone collagen." @default.
• W1964037690 created "2016-06-24" @default.
• W1964037690 creator A5003690739 @default.
• W1964037690 creator A5006662504 @default.
• W1964037690 creator A5019640303 @default.
• W1964037690 creator A5045507551 @default.
• W1964037690 creator A5046915476 @default.
• W1964037690 creator A5058476835 @default.
• W1964037690 creator A5062096250 @default.
• W1964037690 creator A5063518304 @default.
• W1964037690 creator A5066820686 @default.
• W1964037690 creator A5091232423 @default.
• W1964037690 date "2000-12-07" @default.
• W1964037690 modified "2023-10-18" @default.
• W1964037690 title "Novel, Nonpeptidic Cyanamides as Potent and Reversible Inhibitors of Human Cathepsins K and L" @default.
• W1964037690 cites W1513574545 @default.
• W1964037690 cites W1863314954 @default.
• W1964037690 cites W1965771018 @default.
• W1964037690 cites W1973573196 @default.
• W1964037690 cites W1977260572 @default.
• W1964037690 cites W2017614987 @default.
• W1964037690 cites W2027069366 @default.
• W1964037690 cites W2030240788 @default.
• W1964037690 cites W2043474724 @default.
• W1964037690 cites W2045703917 @default.
• W1964037690 cites W2052414693 @default.
• W1964037690 cites W2099942617 @default.
• W1964037690 cites W2951127528 @default.
• W1964037690 doi "https://doi.org/10.1021/jm0003440" @default.
• W1964037690 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11141092" @default.
• W1964037690 hasPublicationYear "2000" @default.
• W1964037690 type Work @default.
• W1964037690 sameAs 1964037690 @default.
• W1964037690 citedByCount "117" @default.
• W1964037690 countsByYear W19640376902012 @default.
• W1964037690 countsByYear W19640376902013 @default.
• W1964037690 countsByYear W19640376902014 @default.
• W1964037690 countsByYear W19640376902015 @default.
• W1964037690 countsByYear W19640376902016 @default.
• W1964037690 countsByYear W19640376902017 @default.
• W1964037690 countsByYear W19640376902018 @default.
• W1964037690 countsByYear W19640376902019 @default.
• W1964037690 countsByYear W19640376902020 @default.
• W1964037690 countsByYear W19640376902021 @default.
• W1964037690 countsByYear W19640376902022 @default.
• W1964037690 countsByYear W19640376902023 @default.
• W1964037690 crossrefType "journal-article" @default.
• W1964037690 hasAuthorship W1964037690A5003690739 @default.
• W1964037690 hasAuthorship W1964037690A5006662504 @default.
• W1964037690 hasAuthorship W1964037690A5019640303 @default.
• W1964037690 hasAuthorship W1964037690A5045507551 @default.
• W1964037690 hasAuthorship W1964037690A5046915476 @default.
• W1964037690 hasAuthorship W1964037690A5058476835 @default.
• W1964037690 hasAuthorship W1964037690A5062096250 @default.
• W1964037690 hasAuthorship W1964037690A5063518304 @default.
• W1964037690 hasAuthorship W1964037690A5066820686 @default.
• W1964037690 hasAuthorship W1964037690A5091232423 @default.
• W1964037690 hasConcept C167844969 @default.
• W1964037690 hasConcept C170493617 @default.
• W1964037690 hasConcept C178790620 @default.
• W1964037690 hasConcept C181199279 @default.
• W1964037690 hasConcept C185592680 @default.
• W1964037690 hasConcept C202751555 @default.
• W1964037690 hasConcept C2776309666 @default.
• W1964037690 hasConcept C2776568683 @default.
• W1964037690 hasConcept C2776980637 @default.
• W1964037690 hasConcept C2780034444 @default.
• W1964037690 hasConcept C538909803 @default.
• W1964037690 hasConcept C55493867 @default.
• W1964037690 hasConcept C57992300 @default.
• W1964037690 hasConcept C71240020 @default.
• W1964037690 hasConcept C74998103 @default.
• W1964037690 hasConceptScore W1964037690C167844969 @default.
• W1964037690 hasConceptScore W1964037690C170493617 @default.
• W1964037690 hasConceptScore W1964037690C178790620 @default.
• W1964037690 hasConceptScore W1964037690C181199279 @default.
• W1964037690 hasConceptScore W1964037690C185592680 @default.
• W1964037690 hasConceptScore W1964037690C202751555 @default.
• W1964037690 hasConceptScore W1964037690C2776309666 @default.
• W1964037690 hasConceptScore W1964037690C2776568683 @default.
• W1964037690 hasConceptScore W1964037690C2776980637 @default.
• W1964037690 hasConceptScore W1964037690C2780034444 @default.
• W1964037690 hasConceptScore W1964037690C538909803 @default.
• W1964037690 hasConceptScore W1964037690C55493867 @default.
• W1964037690 hasConceptScore W1964037690C57992300 @default.
• W1964037690 hasConceptScore W1964037690C71240020 @default.
• W1964037690 hasConceptScore W1964037690C74998103 @default.
• W1964037690 hasIssue "1" @default.
• W1964037690 hasLocation W19640376901 @default.
• W1964037690 hasLocation W19640376902 @default.
• W1964037690 hasOpenAccess W1964037690 @default.
• W1964037690 hasPrimaryLocation W19640376901 @default.
• W1964037690 hasRelatedWork W1976505897 @default.
• W1964037690 hasRelatedWork W1995545479 @default.
• W1964037690 hasRelatedWork W2032521164 @default.
• W1964037690 hasRelatedWork W2032893243 @default.
• W1964037690 hasRelatedWork W2067102677 @default.
• W1964037690 hasRelatedWork W2178558875 @default.

• next